| The Nordic countries as a cohort for pharmacoepidemiological research K Furu, B Wettermark, M Andersen, JE Martikainen, AB Almarsdottir, ... Basic & clinical pharmacology & toxicology 106 (2), 86-94, 2010 | 651 | 2010 |
| Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study J Hallas, M Dall, A Andries, BS Andersen, C Aalykke, JM Hansen, ... Bmj 333 (7571), 726, 2006 | 610 | 2006 |
| Statins and risk of polyneuropathy: a case-control study D Gaist, U Jeppesen, M Andersen, LAG Rodríguez, J Hallas, SH Sindrup Neurology 58 (9), 1333-1337, 2002 | 421 | 2002 |
| Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study A Pottegård, LC Lund, Ø Karlstad, J Dahl, M Andersen, J Hallas, ... bmj 373, 2021 | 418 | 2021 |
| Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study R Bodén, M Lundgren, L Brandt, J Reutfors, M Andersen, H Kieler Bmj 345, 2012 | 278 | 2012 |
| SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study A Husby, JV Hansen, E Fosbøl, EM Thiesson, M Madsen, RW Thomsen, ... bmj 375, 2021 | 275 | 2021 |
| The Nordic prescription databases as a resource for pharmacoepidemiological research—a literature review B Wettermark, H Zoëga, K Furu, M Korhonen, J Hallas, M Nørgaard, ... Pharmacoepidemiology and drug safety 22 (7), 691-699, 2013 | 228 | 2013 |
| Contacts to the health care system prior to suicide: a comprehensive analysis using registers for general and psychiatric hospital admissions, contacts to general practitioners … UA Andersen, M Andersen, JU Rosholm, LF Gram Acta Psychiatrica Scandinavica 102 (2), 126-134, 2000 | 222 | 2000 |
| Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications B Godman, W Shrank, M Andersen, C Berg, I Bishop, T Burkhardt, ... Expert review of pharmacoeconomics & outcomes research 10 (6), 707-722, 2010 | 211 | 2010 |
| Exposure to potential drug interactions in primary health care L Bjerrum, M Andersen, G Petersen, J Kragstrup Scandinavian journal of primary health care 21 (3), 153-158, 2003 | 204 | 2003 |
| Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study S Bak, I Tsiropoulos, JO Kjærsgaard, M Andersen, E Mellerup, J Hallas, ... Stroke 33 (6), 1465-1473, 2002 | 191 | 2002 |
| Drug utilization research: methods and applications M Elseviers, B Wettermark, AB Almarsdóttir, M Andersen, R Benko, ... John Wiley & Sons, 2016 | 183* | 2016 |
| Maternal vaginal microflora during pregnancy and the risk of asthma hospitalization and use of antiasthma medication in early childhood CS Benn, P Thorsen, JS Jensen, BB Kjær, H Bisgaard, M Andersen, ... Journal of Allergy and Clinical Immunology 110 (1), 72-77, 2002 | 161 | 2002 |
| Policies to enhance prescribing efficiency in Europe: findings and future implications B Godman, W Shrank, M Andersen, C Berg, I Bishop, T Burkhardt, ... Frontiers in pharmacology 1, 141, 2011 | 154 | 2011 |
| Cancer risk in users of calcium channel blockers JH Olsen, HT Sørensen, S Friis, JK McLaughlin, FH Steffensen, ... Hypertension 29 (5), 1091-1094, 1997 | 150 | 1997 |
| Rising prevalence of diabetes: evidence from a Danish pharmacoepidemiological database. H Støvring, M Andersen, H Beck-Nielsen, A Green, W Vach The Lancet 362 (9383), 537-538, 2003 | 148 | 2003 |
| Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder R Bodén, L Brandt, H Kieler, M Andersen, J Reutfors Schizophrenia Research 133 (1-3), 36-41, 2011 | 143 | 2011 |
| Methods for time-varying exposure related problems in pharmacoepidemiology: an overview L Pazzagli, M Linder, M Zhang, E Vago, P Stang, D Myers, M Andersen, ... Pharmacoepidemiology and drug safety 27 (2), 148-160, 2018 | 142 | 2018 |
| Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis I Tsiropoulos, M Andersen, J Hallas Pharmacoepidemiology and drug safety 18 (6), 483-491, 2009 | 141 | 2009 |
| Use of insulin and insulin analogs and risk of cancer—systematic review and meta-analysis of observational studies O Karlstad, J Starup Linde, P Vestergaard, V Hjellvik, M T Bazelier, ... Current drug safety 8 (5), 333-348, 2013 | 139 | 2013 |
